US20230210390A1 - Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties - Google Patents
Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties Download PDFInfo
- Publication number
- US20230210390A1 US20230210390A1 US18/001,188 US202118001188A US2023210390A1 US 20230210390 A1 US20230210390 A1 US 20230210390A1 US 202118001188 A US202118001188 A US 202118001188A US 2023210390 A1 US2023210390 A1 US 2023210390A1
- Authority
- US
- United States
- Prior art keywords
- light
- tissue
- signal
- wearable device
- frequency bands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003287 optical effect Effects 0.000 title description 21
- 238000005259 measurement Methods 0.000 title description 16
- 230000004071 biological effect Effects 0.000 title description 7
- 230000000694 effects Effects 0.000 title description 6
- 238000000034 method Methods 0.000 claims abstract description 38
- 210000001519 tissue Anatomy 0.000 claims description 109
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 16
- 210000004204 blood vessel Anatomy 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 14
- 239000001301 oxygen Substances 0.000 claims description 14
- 102000001554 Hemoglobins Human genes 0.000 claims description 8
- 108010054147 Hemoglobins Proteins 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 230000036772 blood pressure Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 229910003798 SPO2 Inorganic materials 0.000 claims description 4
- 101100478210 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spo2 gene Proteins 0.000 claims description 4
- 230000002093 peripheral effect Effects 0.000 claims description 4
- 230000036387 respiratory rate Effects 0.000 claims description 4
- 206010020112 Hirsutism Diseases 0.000 claims description 3
- 230000006870 function Effects 0.000 claims 2
- 230000037182 bone density Effects 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- 239000000758 substrate Substances 0.000 description 29
- 210000003491 skin Anatomy 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000000691 measurement method Methods 0.000 description 11
- 238000001514 detection method Methods 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 238000009532 heart rate measurement Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000013186 photoplethysmography Methods 0.000 description 2
- 238000002106 pulse oximetry Methods 0.000 description 2
- 238000011896 sensitive detection Methods 0.000 description 2
- 241001331845 Equus asinus x caballus Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
- A61B5/02427—Details of sensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/681—Wristwatch-type devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
- G01N21/53—Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke
- G01N21/532—Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke with measurement of scattering and transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0064—Body surface scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4261—Evaluating exocrine secretion production
- A61B5/4266—Evaluating exocrine secretion production sweat secretion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4872—Body fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
- A61B5/7214—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using signal cancellation, e.g. based on input of two identical physiological sensors spaced apart, or based on two signals derived from the same sensor, for different optical wavelengths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
- A61B2562/0242—Special features of optical sensors or probes classified in A61B5/00 for varying or adjusting the optical path length in the tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/473—Compensating for unwanted scatter, e.g. reliefs, marks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/02—Mechanical
- G01N2201/021—Special mounting in general
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/123—Conversion circuit
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/124—Sensitivity
- G01N2201/1242—Validating, e.g. range invalidation, suspending operation
Definitions
- the present invention is generally in the field of optical measurement of biological properties of an examined subject, and to an optical measurement of blood related parameters of the examined subject.
- the present invention relates to a device to measuring certain features of optical measurement of blood detected by a detector.
- the device improves the signal to noise ratio by mitigation of extraneous noise of the optical measurements detected by the detector.
- optical blood pulse measurements may be carried out utilizing transmissive measurement techniques requiring sensor devices that are mountable over two opposite sides of a thin body part/organ (e.g., fingertip or earlobe).
- transmissive measurement techniques requiring sensor devices that are mountable over two opposite sides of a thin body part/organ (e.g., fingertip or earlobe).
- reflective measurement techniques use a light source and a light detector which are on the same side of a tissue.
- reflective blood measurement techniques there are various advantages for reflective blood measurement techniques, which may be considered to be preferable in certain applications, particularly in types of wearable medical devices, such as medical watches or patches.
- Some of the advantages of reflective blood measurement techniques include, among other things, the ability to conduct optical measurements on almost any part of the body, including thick organs.
- Other advantages may be associated with the reduced energy consumption of reflective measurement techniques, The reduced energy consumption stems from the minimal energy required to reflect light from tissue layers, as opposed to transmissive techniques where the light is required to pass through the entire width of the organ.
- Alternating current (AC) in the light detector as a result of the light detection of the light wave signals received from (capillary) blood vessels may originate from the heart activity.
- the received light signals may be reflected back from the blood vessel towards the device from which the light signal was emitted, or be transmitted via the body tissue, having the light detector placed on another side of the body tissue than the light emitter.
- Direct current (DC) in the light detector as a result of the light detection of the light wave signals may be a combination of light wave signals reflected from other parts of the examined organ tissue and light wave signals reflected directly from the organ surface which do not pass through the examined tissue.
- Attempts to overcome limitations of reflective measurement techniques may include increasing the power of the irradiated light, by increasing the electrical current supplied to the light source and/or by increasing the number of light sources. Increasing the power of radiated light and/or increasing the number of light sources may also result in a respective increase of noise components in the measured light signals.
- the respective increase of noise components in the measured light signals may be due to respective increase of the baseline DC component and thus may not provide satisfying results.
- the increase of noise components in the measured light signals may additionally be due to movement of the sensing device attached to a user when the user is moving or exercising. There is therefore a need to improve the quality of optical signals measured by reflective blood measurements techniques, to provide higher AC/DC ratios and improve the signal-to-noise ratios of the measured light signals.
- the subject matter discloses a method for a wearable device to determine a biological parameter of a tissue of a person.
- the subject matter discloses emitting a first wavelength and a second wavelength of light towards the tissue, and collecting a first and a second signals received from the first and the second wavelengths respectively.
- the first and second received signals are represented based on a set of frequency bands as elaborated below.
- the first set of values in the frequency bands represents a first received signal which corresponds to a combination of the biological parameter and an extraneous noise.
- the second set of values in the frequency bands represents a second received signal mainly comprising the extraneous noise.
- the subject matter also comprises subtracting the first set of values in the frequency bands from the second set of values in the frequency bands in the frequency domain to obtain a third set of values in the frequency bands.
- the third set of values in the frequency bands represents a third signal corresponding to the biological parameter, substantially lacking the extraneous noise.
- collecting and sensing the first and the second set of values in the frequency bands may be responsive to a delay to apply the first wavelength followed by the second wavelength of light towards the tissue. In some cases, collecting and sensing the first and the second set of values in the frequency bands may be responsive to the applying of the first wavelength and the second wavelength of light at the same time towards the tissue.
- the method of the subject matter may further disclose an analysis of the third signal by a processing of the third signal.
- the method of the subject matter may also disclose displaying the biological parameter on a display of the wearable device responsive to the analysis of the third signal.
- the processing may be by a Fourier transform applied on the third signal.
- the extraneous noise may be generated by movement at least one of the tissues and the body of the person.
- the emitting of the first and the second wavelength of light may be performed laterally in a direction away from a sensor doing the sensing.
- the emitting of the first and the second wavelengths of light may penetrate respective first and second depths of the tissue.
- the subtracting of the first set of values in the frequency bands from the second set of values in the frequency bands in the frequency domain may be performed responsive to detection of a movement of the person and/or the tissue.
- the biological parameter may be a heart rate, a respiratory rate, a peripheral capillary oxygen saturation rate (SPO2), a hemoglobin level, a perspiration level, a blood pressure, a glucose level, a bilirubin level, a stroke volume or a fat level.
- SPO2 peripheral capillary oxygen saturation rate
- the subject matter also discloses a wearable device to determine a biological parameter of a tissue of a person.
- the wearable device includes a processing module operatively attached to a display.
- the wearable device also includes a light emitter operatively connected to the processing module and configured to emit a first wavelength and a second wavelength of light towards the tissue.
- the wearable device also includes a light sensor operatively connected to the processing module and configured to sense a first and a second signals received from the first and the second wavelengths respectively.
- the first received signal corresponding to a combination of the biological parameter and an extraneous noise and the second received signal mainly comprising the extraneous noise.
- the processing module is configured to convert the first received signal and the second received signal to a frequency domain, to be represented by a series of values, each value is associated with a frequency band.
- the first received signal is represented by a first set of values in the frequency domain and the second received signal is represented by a second set of values in the frequency domain.
- the wearable device comprises a differential amplifier having a first input and a second input connected respectively to the first signal and the second signal.
- the amplifier may be used to amplify the signal received via the photo diode from the body tissue and convert the received signals to analog signals.
- the wearable device may further include a lens mounted to a distal end of the light emitter and configured to emit the first and the second wavelength as a collimated light towards the tissue.
- the collimated light may be in a direction away laterally from the light sensor towards the tissue by an offset of a lens.
- the wearable device may further include a reflector disposed between the light emitter and the light sensor. The light from light emitter may be reflected by the reflector in a direction away laterally from the light sensor towards the tissue.
- the wearable device may further include a memory module operatively attached to the processing module, the memory module may store the first and second set of values in the frequency bands.
- the emitting of the first and the second wavelength of light may be performed laterally in a direction away from the light sensor.
- the emitting of the first and the second wavelength of light may penetrate respective first and second depths of the tissue.
- the biological parameter may be a heart rate, a respiratory rate, a peripheral capillary oxygen saturation rate (SPO2), a hemoglobin level, a perspiration level, a blood pressure, a glucose level, a bilirubin level, a stroke volume or a fat level.
- SPO2 peripheral capillary oxygen saturation rate
- FIG. 1 shows an illustration of an application of a sensor device to an examined tissue, according to one or more illustrative aspects of the disclosure.
- FIG. 2 A shows a partial system block diagram and a positional location of a substrate relative to a tissue sample, according to one or more illustrative aspects of the disclosure.
- FIG. 2 B shows an implementation of a substrate, according to one or more illustrative aspects of the disclosure.
- FIG. 2 C shows an implementation of a substrate, according to one or more illustrative aspects of the disclosure.
- FIG. 2 D shows an implementation of a substrate, according to one or more illustrative aspects of the disclosure.
- FIG. 3 illustrate features of an area of light interaction in perfused tissue layers, according to one or more illustrative aspects of the disclosure.
- FIG. 4 shows a method for measuring and processing light signals received from blood tissues, according to one or more illustrative aspects of the disclosure.
- FIG. 5 shows a schematic representation for a device for extracting a biological parameter of a tissue of a person, according to one or more illustrative aspects of the disclosure.
- FIG. 6 shows three signals in the frequency domain that represent the method for extracting a biological parameter of a tissue of a person, according to one or more illustrative aspects of the disclosure
- the present invention discloses an optical sensor device, whereby a structure of the optical sensor device provides illumination of an examined tissue with light signals that travel laterally and away from a light detector included in the optical sensor device.
- a structure of the optical sensor device provides illumination of an examined tissue with light signals that travel laterally and away from a light detector included in the optical sensor device.
- Features of the structure enable received optical signals to be measured from the examined tissue with SNR and AC/DC ratios of the received optical signals to be significantly improved.
- the reflective measurement techniques and a structure of a sensor device disclosed herein are also useful for mitigation of optical signal distortions that may be induced in the measured signals of the light detector due to movements of the body part/organ to which the sensor device is attached.
- the techniques disclosed herein are applicable to almost any type of optical measurements of blood properties, parameters and/or analytes, employing effects of optical absorption and scattering of electromagnetic radiation in a living tissue.
- the techniques disclosed herein are useful for measuring pulsating signals, as typically obtained in types of non-invasive blood measurements, such as, but not limited to, pulse oximetry, Photoplethysmography (PPG) measurements, and the like.
- the optical measurement techniques disclosed herein may be useful for measuring blood pulses, oxygen (O 2 ) saturation, hemoglobin levels, glucose/sugar bilirubin levels, and suchlike.
- FIG. 1 shows an illustration of the application of a sensor device to an examined tissue, according to one or more illustrative aspects of the disclosure.
- Sensor device 10 is an example of a reflective optical measurement device which is illustrated in further detail below.
- Sensor device 10 (shown by dashed line) is located on the underside of a housing 12 so that reflectors 24 (shown by dashed line) of sensor device 10 are in contact with the skin of a wrist of a user. Other sensor devices may be placed near other users' tissues.
- Light emitters 22 are shown by dotted line and are configured to emit light towards the user's skin.
- the wearable device also comprises a light detector 26 shown by hashed lines located on the underside of housing 12 .
- Housing 12 includes a display 13 , for example being located on the housing's 12 upper surface, away from the user's skin.
- the light emitters 22 may be arranged in a circle-like shape, having the light detector 26 at the center of the circle.
- the wearable device comprises multiple circles of light emitters 22 positioned concentrically to each other. Multiple circles of light emitters 22 may provide the option for illumination of the user's skin at different lateral distances away from light detector 26 .
- Housing 12 is shown as a watch arrangement where an adjustable strap 15 is used to attach the watch to the user's wrist.
- a side view 100 of the underside of a housing 12 is shown where adjustable strap 15 is attached to housing 12 , substrate 20 is operatively attached inside housing 12 both mechanically and electrically and may protrude away out from housing 12 and includes connection to a battery 17 .
- Substrate 20 includes traces (not shown) or other mechanisms which provide the electrical interconnections of the components of the sensor device 10 which require electrical power and connection, for example display 13 , battery 17 and a micro control unit (MCU) (not shown).
- Sensor device 10 is both mechanically and electrically connected to housing 12 , substrate 20 and battery 17 .
- Adjustable strap 15 may be tightened around the user's wrist to secure sensor device 10 onto a part of the user's body.
- the body part may be an ankle or around a torso of the person.
- Adjustable strap 15 may enable a biological property of an examined tissue of the person who is currently exercising or is monitored over a long period of time.
- the biological property may include heart rate, oxygen saturation, hemoglobin level, blood pressure, cardiac output, stroke volume, perspiration, glucose/sugar level, bilirubin level and fat level for example.
- the biological property may be displayed on display 13 .
- FIG. 2 A shows a partial system block diagram and a positional location of substrate 20 relative to a tissue 262 , according to one or more illustrative aspects of the disclosure.
- substrate 20 may provide a mechanical attachment of multiple reflectors 24 , light emitters 22 and light detector 26 to substrate 20 .
- the multiple reflectors 24 may be in contact with the skin of tissue 262 .
- FIG. 2 A shows an example of a deployment of sensor 10 without reflectors 24 .
- light emitters 22 and light detector 26 are shown embedded below the surface of substrate 20 .
- Additional components may be included and interconnected in or connected to substrate 20 .
- the additional components may include driver circuitries utilized to set current levels, light intensities and wavelengths of the light signals S ⁇ 1 or S ⁇ 2 emitted from light emitters 22 .
- Light emitters 22 may be multicolor light emitting diodes (LEDs). Multicolor LEDs typically have three selectable wavelengths of red light (wavelength[ ⁇ ] ⁇ 670 nano-meters[nm]), blue ( ⁇ 460 nm) and green ( ⁇ 550 nm).
- Received light wave signals RS ⁇ 1 or RS ⁇ 2 having an angle ⁇ from the parts of tissue 262 may be a combination of light wave signals received from the tissue layers S 1 -S 5 of tissue 262 .
- Alternating current (AC) in light detector 26 is a result of a light detection of the light wave signals RS ⁇ 1 or RS ⁇ 2 received from (capillary) blood vessels 260 from remote perfused tissue layers, S 3 , S 4 and S 5 .
- the light detection may therefore originate from the heart activity of a person wearing sensor device 10 .
- Direct current (DC) in light detector 26 may be measured as a result of the light detection of the light wave signals RS ⁇ 1 or RS ⁇ 1 received directly from near-surface tissue layers S 1 and S 2 which form the epidermis of the skin.
- Direct current (DC) in light detector 26 may also include light detection of the light wave signals RS ⁇ 1 or RS ⁇ 2 received from remote perfused tissue layers, S 3 , S 4 and S 5 .
- the received signals RS ⁇ 1 or RS ⁇ 2 are inputted into a first conversion module 21 that converts the received signals RS ⁇ 1 or RS ⁇ 2 into the frequency domain. Such conversion may be implemented by applying a Fourier transform on the received signals RS ⁇ 1 or RS ⁇ 2 or via any other conversion to the frequency domain desired by a person skilled in the art.
- the Output of the first conversion module 21 comprises a set of values associated with multiple frequency hands. For example, the entire set of values may he in the range of 0-10 Hertz. In that range, there may be 20 frequency bands, each hand of 0.5 Hertz.
- the values associated with all the frequency bands represent the output of the conversion of the received signals RS ⁇ 1 or RS ⁇ 2 into the frequency domain.
- the two sets of values, one for each of the received signals, which are outputted by the first conversion module 21 may be stored in predefined memory addresses in the device used for determining the physical properties of the person, for example a wearable watch.
- the device also comprises a subtraction module 22 configured to subtract one set of values from the other.
- the first set of values represents values of the first signal in the multiple frequency bands while the second set of values represents values of the second signal in the multiple frequency hands.
- the subtraction is defined by subtracting the values associated with each frequency band. For example, subtracting the value of RS ⁇ 1 in the fifth band from the value of RS ⁇ 2 in the fifth band to compute the signal itself, without the noise generated by movement of the person.
- the output of the subtraction module 22 comprises a set of values in the multiple frequency bands which represents the signal without the noise created due to the person's movement.
- the device also comprises a second conversion module 23 configured to convert the output of the subtraction module 22 from the frequency domain into the time domain.
- the time domain representation may show a sinusoidal signal, which lacks the noise created due to the person's movement.
- the second conversion module 23 may output the time domain representation of the signal, without the noise component, to a predefined memory address in the device.
- Circuit may connect between substrate 20 and electrical components elaborated in FIG. 5 .
- Circuit may include a differential amplifier which receives voltages and currents representative of light signal RS ⁇ 1 on its non-inverting input and voltages and currents representative of light signal RS ⁇ 2 on its inverting input via delay line DL 1 .
- Delay DL 1 is utilized where light signals RS ⁇ 2 are applied one after the other.
- the delay of delay DL 1 and the bias of differential amplifier allows difference amplifier to perform a subtraction of light signal RS ⁇ 1 from light signal RS ⁇ 2 .
- the subtraction may be useful to obtain more of the AC in light detector 26 as resulting light signal RS ⁇ 3 .
- Light signal RS ⁇ 1 relates to the heart activity of a person wearing sensor device and is the major part of light signal RS ⁇ 1 since respective emitted light signal S 1 penetrates tissues layers S 3 , S 4 and S 5 more deeply than light signal S ⁇ 2 does.
- the subtraction of light signal RS ⁇ 1 from light signal RS ⁇ 2 is therefore aimed at subtracting the DC detected included in signal RS ⁇ 1 from the combination of AC and DC of signal RS ⁇ 2 .
- the subtraction may also be used to mitigate the effects of an unwanted signal component included and in common to light signals RS ⁇ 1 and RS ⁇ 1 .
- the unwanted signal component may be referred to as an extraneous noise.
- the extraneous noise may due to a displacement in the positional location of substrate 20 relative to the tissue 262 as referenced with respect to cartesian coordinates x,y and z.
- the displacement of the substrate on the user's skin may be caused by movement of the body or a limb of a person wearing the sensor device 10 when walking or running.
- the displacement of substrate 20 on the user's skin may also include localized movement of tissue 262 as a result of flexing a muscle.
- Circuit may include other analogue circuitry, for example a lock-in amplifiers with phase sensitive detection properties.
- the phase sensitive detection properties may be utilized just on light signal RS ⁇ 1 to eliminate extraneous noise signals at frequencies other than the fundamental frequency component of light signal RS ⁇ 1 .
- the resulting light signal RS ⁇ 3 may then be processed to display a biological property such as heart rate, oxygen saturation, hemoglobin level, blood pressure, cardiac output, stroke volume, perspiration, glucose/sugar level, bilirubin level and fat level for example.
- FIG. 2 B shows an implementation of substrate 20 , according to one or more illustrative aspects of the disclosure.
- Substrate 20 is the same as the substrate 20 in FIG. 2 A , with the addition of lens L 1 which is placed on a distal end of light emitter 22 .
- Light signals S ⁇ 1 or S ⁇ 2 are emitted from light emitter 22 at an angle substantially perpendicular to a first planar surface of substrate 20 .
- the first planar surface of substrate 20 is indicated by dotted line 28 .
- Lens L 1 provides collimated light signals S ⁇ 1 ′ or S ⁇ 2 ′ to be outputted towards the user's tissue 262 , as opposed to scattered light signals S ⁇ 1 or S ⁇ 2 shown in FIG. 2 A .
- Lens L 1 may also include a polarizing filter (not shown) which polarizes collimated light signals S ⁇ 1 ′ or S ⁇ 2 ′.
- Received light wave signals RS ⁇ 1 ′ or RS ⁇ 1 ′ are reflected towards light detector 26 at an angle ⁇ from layers S 1 -S 5 of tissue 262 .
- Received light wave signals RS ⁇ 1 ′ or RS ⁇ 1 ′ may carry both DC and AC components when detected in light detector 26 .
- Received light wave signals S ⁇ 1 ′ or S ⁇ 2 ′ received at angle ⁇ , from the tissue layers S 1 -S 5 of tissue 262 have signal properties that depend on parameters such as the wavelengths of light signals emitted from light emitter 22 with or without lens L 1 , properties of the lens L 1 distance d 1 between the light emitter 22 and the light detector 26 , a displacement in the positional location of substrate 20 relative to a tissue 262 , movement properties of a person wearing sensor device 10 and the like.
- FIG. 2 C shows an implementation of substrate 20 , according to one or more illustrative aspects of the disclosure.
- FIG. 2 C is the same as FIG. 2 A with respect to substrate 20 , having an addition of lens L 1 which is placed on a distal end of light emitter 22 and offset laterally towards light detector 26 .
- Light signals are emitted from light emitter 22 at an angle substantially perpendicular to a first planar surface of substrate 20 .
- the first planar surface of substrate 20 is indicated by dotted line 28 .
- lens L 1 causes light signals S ⁇ 1 ′ or S ⁇ 2 ′ to be deflected away from light detector 26 by virtue of lens L 1 laterally offsetting the light signals towards light detector 26 .
- Lens L 1 provides collimated light signals S ⁇ 1 ′ or S ⁇ 2 ′ as opposed to scattered light signals S ⁇ 1 or S ⁇ 2 shown in FIG. 2 A .
- Received light wave signals RS ⁇ 1 ′ or RS ⁇ 1 ′ received from tissue 262 towards light detector 26 are at an angle ⁇ from layers S 1 -S 5 of tissue 262 .
- angle ⁇ is likely to be more acute than angle ⁇ and the distance away from light detector 26 where light signals S ⁇ 1 ′ or S ⁇ 2 ′ are received in tissue 262 is much greater than where light signals S ⁇ 1 or S ⁇ 2 are received from tissue 262 .
- Lens L 1 may also include a polarizing filter (not shown) which polarizes collimated light signals S ⁇ 1 ′ or S ⁇ 2 ′. Utilization of offset lens L 1 here eliminates the use of a reflector 24 to direct light signals away from light detector 26 . Therefore, sensor device 10 may include multiple light emitters 22 and respective lenses L 1 without any reflectors 24 . Another embodiment discloses the sensor device 10 having a combination of light emitters 22 and reflectors 24 , light emitters 22 /lenses L 1 and reflectors 24 , or light emitters 22 /lenses L 1 and no reflectors 24 .
- FIG. 2 D shows an implementation of substrate 20 , according to one or more illustrative aspects of the disclosure. Similar to FIG. 2 B , lens L 1 is placed on a distal end of light emitter 22 . Light is emitted from light emitter 22 at an angle substantially perpendicular to a first planar surface of substrate 20 (shown by dotted line 28 ). However, the embodiment shown in FIG. 2 D includes a reflector 24 mounted to substrate 20 between light detector 26 and light emitter 22 . Light is emitted from light emitter 22 and is received off reflector 24 as light signals S ⁇ 1 ′ or S ⁇ 2 ′.
- Light signals S ⁇ 1 ′ or S ⁇ 2 ′ then penetrate into tissue 262 away from light detector 26 and are received from tissue layers S 1 -S 5 towards light detector 26 at an angle ⁇ .
- angle ⁇ is likely to be more acute than angles ⁇ and ⁇ .
- Light signals S ⁇ 1 ′ or S ⁇ 2 ′ penetrate into tissue 262 away at a greater distance from light detector 26 than as shown in preceding FIGS. 2 B- 2 C .
- the more acute angle ⁇ and the greater distance may also permit a deeper penetration into tissue 262 .
- FIG. 3 illustrates features of an area of light interaction in perfused tissue layers S 1 -S 5 , according to one or more illustrative aspects of the disclosure.
- Area 38 a (shown shaded) includes intersection of illumination sector 36 a with perfused layers S 3 -S 5 that coincides within a portion of sector 34 .
- Illumination sector 36 a is formed by light signals S ⁇ 1 , S ⁇ 1 ′ or S ⁇ 2 , S ⁇ 2 ′ (not shown) which may be reflected off reflector 24 and/or directed by offset lens L 1 into tissue 262 .
- Light signals RS ⁇ 3 , RS ⁇ 4 and RS ⁇ 5 are reflected towards light detector 26 from respective perfused tissue layers S 3 , S 4 and S 5 .
- the field of view of reception of received light signals of light detector 26 is indicated by sector 34 .
- Light intersection area 38 a in perfused tissue layers S 3 , S 4 and S 5 is therefore dependent on angle ⁇ relative to dashed line 28 , so that light components RS ⁇ 3 , RS ⁇ 4 and RS ⁇ 5 are reflected towards light detector 26 from perfused tissue layers S 3 , S 4 and S 5 .
- the baseline DC components in the optical signals measured by the light detector 26 in the reflective measurement are substantially reduced, by reducing the amount (or altogether excluding) of light components RS ⁇ 1 and RS ⁇ 2 (not shown), received from respective non-perfused tissue layers S 1 and S 2 .
- the optical paths, of the light components RS ⁇ 3 , RS ⁇ 4 and RS ⁇ 5 received towards the light detector 26 from the perfused tissue layers are increased by virtue of angle ⁇ .
- the light components RS ⁇ 3 , RS ⁇ 4 and RS ⁇ 5 indicate a more intense interaction with perfused tissue layers S 3 , S 4 and S 5 .
- light components RS ⁇ 3 , RS ⁇ 4 and RS ⁇ 5 may contain significantly more blood related information from pulsating blood vessels 260 and contribute greater amounts of pulsating AC components to the optical signals captured and measured by light detector 26 .
- Step 410 discloses emitting light signals from a light emitter 26 of the sensor device 10 .
- the light signals comprise at least two signals, a first signal in a predefined wavelength to include the blood measurements combined with noise, and a second light signal meant to include noise only.
- the second signal is inert to changes in blood vessels of the tissue to which the light signal is emitted.
- the second signal may be emitted in wavelength of 1440 nanometer,
- the first and second signal emitted towards the user's tissue may be defined as light signals S ⁇ 1 or S ⁇ 2 respectively.
- Light signals S ⁇ 1 or S ⁇ 2 may pass through one or more components, such as a reflector, lens and the like, as described above.
- Circuit may include sample and hold circuitry with analogue to digital converters (ADCs) to give a binary digital representation of a series of values associated with specific frequency bands of received light signals RS ⁇ 1 or RS ⁇ 2 .
- ADCs analogue to digital converters
- a light signal When a light signal enters the body tissue, it is scattered in all directions or bounced around by blood cells and other structures (blood vessels 260 ) in tissue 262 .
- the light may either be absorbed into the tissue, or reflect from near-surface tissue layers S 1 and S 2 which form the epidermis of the skin.
- Veins such as blood vessels 260 unlike arteries carry deoxygenated blood, the deoxygenated blood absorbs more red light than the oxygen rich blood in the tissue around the vein.
- the processing module disclosed below may determine chooses which light emitter 22 to be used to emit light signals S ⁇ 1 and S ⁇ 2 towards tissue 262 .
- the measure of pulse rate which may be derived from blood vessels 260
- light signals S ⁇ 1 and S ⁇ 2 are set at wavelengths respectively which do and do not absorb in the blood of tissue 262 .
- For pulse measurement light signal S ⁇ 1 has a red wavelength and light signal S ⁇ 2 has a wavelength of 1440 nm.
- two light signals are received from the body tissue.
- the two light signals are collected by light detector 26 as a result of light signals S ⁇ 1 and S ⁇ 2 emitted according to step 410 and received from tissue layers S 1 -S 5 as respective received light signals RS ⁇ 1 and RS ⁇ 2 .
- respective received light signals RS ⁇ 1 and RS ⁇ 2 will have different levels of absorption and different depths of absorption in tissue 262 .
- the measure of pulse rate the movement of blood vessel 260 will cause both direct current and an alternating current to be collected and measured by light detector 26 from received light signal RS ⁇ 1 .
- the conversion module of the device which performs the process converts the first received signal and the second received signal from the time domain to the frequency domain.
- the converted signals may carry information sampled for at least one (1) second. In some other cases, the received signals contain information sampled for a duration in the range of 1-10 seconds.
- the output of the conversion to the frequency domain may be represented as two series of values associated with frequency bands.
- the first series of values is of the first received signal and the second series of values is of the second received signal circuit 20 may include sample and hold circuitry with analogue to digital converters (ADCs) which allows a binary digital representation of received light signal RS ⁇ 1 and received light signal RS ⁇ 2 in the frequency domain.
- ADCs analogue to digital converters
- the binary digital representation of received light signal RS ⁇ 1 and received light signal RS ⁇ 2 in the frequency domain may be streamed via wireless transceiver 206 to cloud 202 and/or Server 204 .
- Server 204 may be located in a LAN.
- the server may perform subtraction step 440 .
- memory module may be utilized by the processing module to perform subtraction step 440 .
- the received light signal RS ⁇ 1 and received light signal RS ⁇ 2 are represented in the frequency domain as a series of values, each value in the series of values is associated with a frequency band. For example, 0.5 in the frequency band of 10 Hz, 0.3 in the frequency band of 20 Hz, 0 in the frequency band of 30 Hz, 2.1 in the frequency band of 40 Hz and the like.
- the received signal RS ⁇ 2 is subtracted from received signal RS ⁇ 1 in the frequency domain. That is, each value in a frequency band is subtracted separately. For example, in case there are 10 frequency bands, each of the received signals received RS ⁇ 1 and RS ⁇ 2 are represented as an array of 10 values, each value represents the amplitude in a specific frequency band. Then, the value in frequency band #1 of RS ⁇ 2 is subtracted from the value in frequency band #1 of RS ⁇ 1 , then the values in frequency band #2 and so forth, such that the output is an array of 10 values. The output of the subtraction is a third signal RS ⁇ 3 .
- RS ⁇ 3 RS ⁇ 1 ⁇ RS ⁇ 2
- the subtraction may also be defined as S 1 (f) ⁇ S 2 (f), as S 1 (f) denotes the first light signal in the frequency domain and S 2 (f),
- the third signal RS ⁇ 3 is converted from the frequency domain to the time domain.
- the output of the third signal RS ⁇ 3 in the time domain may be a sinusoidal signal.
- FIG. 5 shows a schematic representation for a device for extracting a biological parameter of a tissue of a person, according to one or more illustrative aspects of the disclosure.
- the device may be a wearable device, such as a watch used to monitor a biological parameter such as pulse.
- a biological parameter such as pulse.
- the device comprises a memory module 510 for storing information used to extract the biological parameter.
- information may be a set of mules and operations used to process the signals received from the patient's body tissue.
- the information may be values representing the received signals, either in the time domain or in the frequency domain.
- the device comprises a sensor module 520 used to collect biological or environmental measurements in the vicinity of the device.
- Sensor module 520 may include an accelerometer, temperature sensor and moisture sensor, Information collected from the sensor module 520 may be used to initiate the process disclosed in FIG. 4 , as the process is also used to overcome noise resulting from the user's movement.
- the device comprises a processing module 530 for performing the conversions and calculations disclosed in the process of FIG. 4 .
- the device comprises a display unit 540 for displaying the biological parameters extracted from the light signals received from the patient's blood tissue.
- FIG. 6 shows three signals in the frequency domain that represent the method for extracting a biological parameter of a tissue of a person, according to one or more illustrative aspects of the disclosure.
- the first signal carries information from the blood vessel located in the tissue.
- the first signal is shown in the time domain 610 , and in the frequency domain 615 , having pulses in 3 different frequency bands,
- the second signal comprises substantially only noise.
- the noise is defined as information resulting from movement of the tissue or movement of the sensor.
- the second signal is shown in the time domain 620 , and in the frequency domain 625 , having pulses in 2 different frequency bands.
- the third signal is the subtraction of the second signal from the second signal.
- the third signal is shown in the time domain 630 , and in the frequency domain 635 , having pulses in one frequency band.
- the reflective measurement techniques disclosed herein are also very useful for portable as the improved SNR and AC/DC ratios they provide mitigates signals distortions that are induced in the measured signals due to movements of the body part/organ to which the sensor device is attached.
- the structure of the present invention enables emission of various wavelengths and measurements of various properties. Some wavelengths are received differently from the same examined tissue. Hence, the present invention also disclosed selecting an optimal combination of angle between the light source and light detector as well as the distance between them.
- the method of the subject matter discloses detecting skin properties of the patient and adjusting light properties of the first light signal and the second light signal according to the detected skin properties.
- the skin properties may be detected based on the light reflected back from the patient's tissue, or from other sensors, such as an image sensor.
- the skin properties may include skin's color, level of skin's transparency, level of skin's width, blood vessel's density near the skin, level or skin's fat, hairiness level and a combination thereof.
- the light properties may include frequency, amplitude, wavelength, duration and a combination thereof.
- the method of the subject matter may also disclose normalizing the second set of values in multiple frequency bands and the first set of values in multiple frequency bands before subtraction. The subtraction may be performed on vectors representing the sets of values.
- the method of the subject matter discloses multiple separate light emitters.
- the distance between the separate light emitters may be in the range of 1-50 millimeters.
- each of the multiple separate light emitters is configured to emit a separate light signal towards the tissue.
- at least two light emitters of the multiple separate light emitters emit light in different light frequencies.
- at least two light emitters of the multiple separate light emitters emit light in different light intensities.
- the processing module adjusts the light intensity of the light signal in case the patient's skin is darker than a set threshold, In some cases, at least one light emitter of the multiple separate light emitters is specifically suitable for fat skin. In some cases, at least one light emitter of the multiple separate light emitters is specifically suitable for dark skin. A light emitter is suitable for a specific skin property according to light properties of the light signals emitted from the light emitters.
- the present invention provides a structure to enable reflective measurement configurations for measuring biological properties of an examined tissue/subject with substantially improved SNR and AC/DC ratios. While particular embodiments of the invention have been described, it will be understood, however, that the invention is not limited thereto, since modifications may be made by those skilled in the art, particularly in light of the foregoing teachings. As will be appreciated by the skilled person, the invention can be carried out in a great variety of ways, employing more than one technique from those described above, all without exceeding the scope of the invention.
Abstract
A method for a wearable device to determine a biological parameter of a tissue of a person. To apply an emitting of a first and a second wavelength of light towards the tissue. To collect and sense a first and a second set of frequency bands from the signals received back from the first and the second wavelengths respectively. The first set of frequency bands represents a first signal which corresponds to a combination of the biological parameter and an extraneous noise. The second set of frequency bands represents a second signal mainly comprising the extraneous noise. To subtract the first set of frequency bands from the second set of frequency bands in the frequency domain to obtain a third set of frequency bands. The third set of frequency bands represents a third signal corresponding to the biological parameter.
Description
- The present invention is generally in the field of optical measurement of biological properties of an examined subject, and to an optical measurement of blood related parameters of the examined subject. In particular the present invention relates to a device to measuring certain features of optical measurement of blood detected by a detector. The device improves the signal to noise ratio by mitigation of extraneous noise of the optical measurements detected by the detector.
- The majority of optical blood pulse measurements (e.g., pulse oximetry) may be carried out utilizing transmissive measurement techniques requiring sensor devices that are mountable over two opposite sides of a thin body part/organ (e.g., fingertip or earlobe). In contrast to transmissive measurement techniques, reflective measurement techniques use a light source and a light detector which are on the same side of a tissue.
- There are various advantages for reflective blood measurement techniques, which may be considered to be preferable in certain applications, particularly in types of wearable medical devices, such as medical watches or patches. Some of the advantages of reflective blood measurement techniques include, among other things, the ability to conduct optical measurements on almost any part of the body, including thick organs. Other advantages may be associated with the reduced energy consumption of reflective measurement techniques, The reduced energy consumption stems from the minimal energy required to reflect light from tissue layers, as opposed to transmissive techniques where the light is required to pass through the entire width of the organ.
- There may be however various limitations associated with the reflective measurement techniques, such as low signal-to-noise ratios (SNR) and low AC/DC ratios. Alternating current (AC) in the light detector as a result of the light detection of the light wave signals received from (capillary) blood vessels may originate from the heart activity. The received light signals may be reflected back from the blood vessel towards the device from which the light signal was emitted, or be transmitted via the body tissue, having the light detector placed on another side of the body tissue than the light emitter. Direct current (DC) in the light detector as a result of the light detection of the light wave signals may be a combination of light wave signals reflected from other parts of the examined organ tissue and light wave signals reflected directly from the organ surface which do not pass through the examined tissue.
- Attempts to overcome limitations of reflective measurement techniques may include increasing the power of the irradiated light, by increasing the electrical current supplied to the light source and/or by increasing the number of light sources. Increasing the power of radiated light and/or increasing the number of light sources may also result in a respective increase of noise components in the measured light signals. The respective increase of noise components in the measured light signals may be due to respective increase of the baseline DC component and thus may not provide satisfying results. The increase of noise components in the measured light signals may additionally be due to movement of the sensing device attached to a user when the user is moving or exercising. There is therefore a need to improve the quality of optical signals measured by reflective blood measurements techniques, to provide higher AC/DC ratios and improve the signal-to-noise ratios of the measured light signals.
- The subject matter discloses a method for a wearable device to determine a biological parameter of a tissue of a person. The subject matter discloses emitting a first wavelength and a second wavelength of light towards the tissue, and collecting a first and a second signals received from the first and the second wavelengths respectively. The first and second received signals are represented based on a set of frequency bands as elaborated below. The first set of values in the frequency bands represents a first received signal which corresponds to a combination of the biological parameter and an extraneous noise. The second set of values in the frequency bands represents a second received signal mainly comprising the extraneous noise. The subject matter also comprises subtracting the first set of values in the frequency bands from the second set of values in the frequency bands in the frequency domain to obtain a third set of values in the frequency bands. The third set of values in the frequency bands represents a third signal corresponding to the biological parameter, substantially lacking the extraneous noise.
- In some cases, collecting and sensing the first and the second set of values in the frequency bands may be responsive to a delay to apply the first wavelength followed by the second wavelength of light towards the tissue. In some cases, collecting and sensing the first and the second set of values in the frequency bands may be responsive to the applying of the first wavelength and the second wavelength of light at the same time towards the tissue.
- The method of the subject matter may further disclose an analysis of the third signal by a processing of the third signal. The method of the subject matter may also disclose displaying the biological parameter on a display of the wearable device responsive to the analysis of the third signal. The processing may be by a Fourier transform applied on the third signal. The extraneous noise may be generated by movement at least one of the tissues and the body of the person.
- The emitting of the first and the second wavelength of light may be performed laterally in a direction away from a sensor doing the sensing. The emitting of the first and the second wavelengths of light may penetrate respective first and second depths of the tissue.
- The subtracting of the first set of values in the frequency bands from the second set of values in the frequency bands in the frequency domain may be performed responsive to detection of a movement of the person and/or the tissue.
- The biological parameter may be a heart rate, a respiratory rate, a peripheral capillary oxygen saturation rate (SPO2), a hemoglobin level, a perspiration level, a blood pressure, a glucose level, a bilirubin level, a stroke volume or a fat level.
- The subject matter also discloses a wearable device to determine a biological parameter of a tissue of a person. The wearable device includes a processing module operatively attached to a display. The wearable device also includes a light emitter operatively connected to the processing module and configured to emit a first wavelength and a second wavelength of light towards the tissue. The wearable device also includes a light sensor operatively connected to the processing module and configured to sense a first and a second signals received from the first and the second wavelengths respectively. The first received signal corresponding to a combination of the biological parameter and an extraneous noise and the second received signal mainly comprising the extraneous noise. The processing module is configured to convert the first received signal and the second received signal to a frequency domain, to be represented by a series of values, each value is associated with a frequency band. The first received signal is represented by a first set of values in the frequency domain and the second received signal is represented by a second set of values in the frequency domain.
- In some cases, the wearable device comprises a differential amplifier having a first input and a second input connected respectively to the first signal and the second signal. The amplifier may be used to amplify the signal received via the photo diode from the body tissue and convert the received signals to analog signals.
- The wearable device may further include a lens mounted to a distal end of the light emitter and configured to emit the first and the second wavelength as a collimated light towards the tissue. The collimated light may be in a direction away laterally from the light sensor towards the tissue by an offset of a lens.
- The wearable device may further include a reflector disposed between the light emitter and the light sensor. The light from light emitter may be reflected by the reflector in a direction away laterally from the light sensor towards the tissue. The wearable device may further include a memory module operatively attached to the processing module, the memory module may store the first and second set of values in the frequency bands.
- The emitting of the first and the second wavelength of light may be performed laterally in a direction away from the light sensor. The emitting of the first and the second wavelength of light may penetrate respective first and second depths of the tissue.
- The biological parameter may be a heart rate, a respiratory rate, a peripheral capillary oxygen saturation rate (SPO2), a hemoglobin level, a perspiration level, a blood pressure, a glucose level, a bilirubin level, a stroke volume or a fat level.
- In order to understand the invention and to see how it may be carried out in practice, embodiments will now be described, by way of non-limiting example only, with reference to the accompanying drawings. Features shown in the drawings are meant to be illustrative of only some embodiments of the invention, unless otherwise implicitly indicated. In the drawings like reference numerals are used to indicate corresponding parts, and in which:
-
FIG. 1 shows an illustration of an application of a sensor device to an examined tissue, according to one or more illustrative aspects of the disclosure. -
FIG. 2A shows a partial system block diagram and a positional location of a substrate relative to a tissue sample, according to one or more illustrative aspects of the disclosure. -
FIG. 2B shows an implementation of a substrate, according to one or more illustrative aspects of the disclosure. -
FIG. 2C shows an implementation of a substrate, according to one or more illustrative aspects of the disclosure. -
FIG. 2D shows an implementation of a substrate, according to one or more illustrative aspects of the disclosure. -
FIG. 3 illustrate features of an area of light interaction in perfused tissue layers, according to one or more illustrative aspects of the disclosure. -
FIG. 4 shows a method for measuring and processing light signals received from blood tissues, according to one or more illustrative aspects of the disclosure. -
FIG. 5 shows a schematic representation for a device for extracting a biological parameter of a tissue of a person, according to one or more illustrative aspects of the disclosure. -
FIG. 6 shows three signals in the frequency domain that represent the method for extracting a biological parameter of a tissue of a person, according to one or more illustrative aspects of the disclosure - One or more specific embodiments of the present disclosure will be described below with reference to the drawings, which are to be considered in all aspects as illustrative only and not restrictive in any manner. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. Elements illustrated in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the invention. This invention may be provided in other specific forms and embodiments without departing from the essential characteristics described herein.
- By way of introduction, the present invention discloses an optical sensor device, whereby a structure of the optical sensor device provides illumination of an examined tissue with light signals that travel laterally and away from a light detector included in the optical sensor device. Features of the structure enable received optical signals to be measured from the examined tissue with SNR and AC/DC ratios of the received optical signals to be significantly improved.
- It is noted that the reflective measurement techniques and a structure of a sensor device disclosed herein are also useful for mitigation of optical signal distortions that may be induced in the measured signals of the light detector due to movements of the body part/organ to which the sensor device is attached.
- The techniques disclosed herein are applicable to almost any type of optical measurements of blood properties, parameters and/or analytes, employing effects of optical absorption and scattering of electromagnetic radiation in a living tissue. Particularly, the techniques disclosed herein are useful for measuring pulsating signals, as typically obtained in types of non-invasive blood measurements, such as, but not limited to, pulse oximetry, Photoplethysmography (PPG) measurements, and the like. For example, and without being limiting, the optical measurement techniques disclosed herein may be useful for measuring blood pulses, oxygen (O2) saturation, hemoglobin levels, glucose/sugar bilirubin levels, and suchlike.
- Reference is now made to
FIG. 1 , which shows an illustration of the application of a sensor device to an examined tissue, according to one or more illustrative aspects of the disclosure.Sensor device 10 is an example of a reflective optical measurement device which is illustrated in further detail below. Sensor device 10 (shown by dashed line) is located on the underside of ahousing 12 so that reflectors 24 (shown by dashed line) ofsensor device 10 are in contact with the skin of a wrist of a user. Other sensor devices may be placed near other users' tissues.Light emitters 22 are shown by dotted line and are configured to emit light towards the user's skin. The wearable device also comprises alight detector 26 shown by hashed lines located on the underside ofhousing 12.Housing 12 includes adisplay 13, for example being located on the housing's 12 upper surface, away from the user's skin. - The
light emitters 22 may be arranged in a circle-like shape, having thelight detector 26 at the center of the circle. In some other embodiments of the subject matter, the wearable device comprises multiple circles oflight emitters 22 positioned concentrically to each other. Multiple circles oflight emitters 22 may provide the option for illumination of the user's skin at different lateral distances away fromlight detector 26.Housing 12 is shown as a watch arrangement where anadjustable strap 15 is used to attach the watch to the user's wrist. - A
side view 100 of the underside of ahousing 12 is shown whereadjustable strap 15 is attached tohousing 12,substrate 20 is operatively attached insidehousing 12 both mechanically and electrically and may protrude away out fromhousing 12 and includes connection to abattery 17.Substrate 20 includes traces (not shown) or other mechanisms which provide the electrical interconnections of the components of thesensor device 10 which require electrical power and connection, forexample display 13,battery 17 and a micro control unit (MCU) (not shown).Sensor device 10 is both mechanically and electrically connected tohousing 12,substrate 20 andbattery 17. -
Adjustable strap 15 may be tightened around the user's wrist to securesensor device 10 onto a part of the user's body. The body part may be an ankle or around a torso of the person.Adjustable strap 15 may enable a biological property of an examined tissue of the person who is currently exercising or is monitored over a long period of time. The biological property may include heart rate, oxygen saturation, hemoglobin level, blood pressure, cardiac output, stroke volume, perspiration, glucose/sugar level, bilirubin level and fat level for example. The biological property may be displayed ondisplay 13. - Reference is now made to
FIG. 2A which shows a partial system block diagram and a positional location ofsubstrate 20 relative to atissue 262, according to one or more illustrative aspects of the disclosure. As shown inFIG. 1 ,substrate 20 may provide a mechanical attachment ofmultiple reflectors 24,light emitters 22 andlight detector 26 tosubstrate 20. Themultiple reflectors 24 may be in contact with the skin oftissue 262.FIG. 2A shows an example of a deployment ofsensor 10 withoutreflectors 24. In contrast toFIG. 1 ,light emitters 22 andlight detector 26 are shown embedded below the surface ofsubstrate 20. - Additional components may be included and interconnected in or connected to
substrate 20. The additional components may include driver circuitries utilized to set current levels, light intensities and wavelengths of the light signals Sλ1 or Sλ2 emitted fromlight emitters 22.Light emitters 22, by way of non-limiting example, may be multicolor light emitting diodes (LEDs). Multicolor LEDs typically have three selectable wavelengths of red light (wavelength[λ]≈670 nano-meters[nm]), blue (λ≈460 nm) and green (λ≈550 nm). Received light wave signals RSμ1 or RSλ2 having an angle α from the parts oftissue 262 may be a combination of light wave signals received from the tissue layers S1-S5 oftissue 262. - Alternating current (AC) in
light detector 26 is a result of a light detection of the light wave signals RSλ1 or RSλ2 received from (capillary)blood vessels 260 from remote perfused tissue layers, S3, S4 and S5. The light detection may therefore originate from the heart activity of a person wearingsensor device 10. Direct current (DC) inlight detector 26 may be measured as a result of the light detection of the light wave signals RSλ1 or RSλ1 received directly from near-surface tissue layers S1 and S2 which form the epidermis of the skin. Direct current (DC) inlight detector 26 may also include light detection of the light wave signals RSλ1 or RSλ2 received from remote perfused tissue layers, S3, S4 and S5. - The received signals RSλ1 or RSλ2 are inputted into a
first conversion module 21 that converts the received signals RSλ1 or RSλ2 into the frequency domain. Such conversion may be implemented by applying a Fourier transform on the received signals RSλ1 or RSλ2 or via any other conversion to the frequency domain desired by a person skilled in the art. The Output of thefirst conversion module 21 comprises a set of values associated with multiple frequency hands. For example, the entire set of values may he in the range of 0-10 Hertz. In that range, there may be 20 frequency bands, each hand of 0.5 Hertz. The values associated with all the frequency bands represent the output of the conversion of the received signals RSλ1 or RSλ2 into the frequency domain. The two sets of values, one for each of the received signals, which are outputted by thefirst conversion module 21 may be stored in predefined memory addresses in the device used for determining the physical properties of the person, for example a wearable watch. - The device also comprises a
subtraction module 22 configured to subtract one set of values from the other. The first set of values represents values of the first signal in the multiple frequency bands while the second set of values represents values of the second signal in the multiple frequency hands. The subtraction is defined by subtracting the values associated with each frequency band. For example, subtracting the value of RSλ1 in the fifth band from the value of RSλ2 in the fifth band to compute the signal itself, without the noise generated by movement of the person. The output of thesubtraction module 22 comprises a set of values in the multiple frequency bands which represents the signal without the noise created due to the person's movement. - The device also comprises a
second conversion module 23 configured to convert the output of thesubtraction module 22 from the frequency domain into the time domain. The time domain representation may show a sinusoidal signal, which lacks the noise created due to the person's movement. Thesecond conversion module 23 may output the time domain representation of the signal, without the noise component, to a predefined memory address in the device. - Circuit may connect between
substrate 20 and electrical components elaborated inFIG. 5 . Circuit may include a differential amplifier which receives voltages and currents representative of light signal RSλ1 on its non-inverting input and voltages and currents representative of light signal RSλ2 on its inverting input via delay line DL1. Delay DL1 is utilized where light signals RSλ2 are applied one after the other. The delay of delay DL1 and the bias of differential amplifier allows difference amplifier to perform a subtraction of light signal RSλ1 from light signal RSλ2. The subtraction may be useful to obtain more of the AC inlight detector 26 as resulting light signal RSλ3. Light signal RSλ1 relates to the heart activity of a person wearing sensor device and is the major part of light signal RSλ1 since respective emitted light signal S1 penetrates tissues layers S3, S4 and S5 more deeply than light signal Sλ2 does. The subtraction of light signal RSλ1 from light signal RSλ2 is therefore aimed at subtracting the DC detected included in signal RSλ1 from the combination of AC and DC of signal RSλ2. The subtraction may also be used to mitigate the effects of an unwanted signal component included and in common to light signals RSλ1 and RSλ1. The unwanted signal component may be referred to as an extraneous noise. The extraneous noise may due to a displacement in the positional location ofsubstrate 20 relative to thetissue 262 as referenced with respect to cartesian coordinates x,y and z. The displacement of the substrate on the user's skin may be caused by movement of the body or a limb of a person wearing thesensor device 10 when walking or running. The displacement ofsubstrate 20 on the user's skin may also include localized movement oftissue 262 as a result of flexing a muscle. - Circuit may include other analogue circuitry, for example a lock-in amplifiers with phase sensitive detection properties. The phase sensitive detection properties may be utilized just on light signal RSλ1 to eliminate extraneous noise signals at frequencies other than the fundamental frequency component of light signal RSλ1. The resulting light signal RSλ3 may then be processed to display a biological property such as heart rate, oxygen saturation, hemoglobin level, blood pressure, cardiac output, stroke volume, perspiration, glucose/sugar level, bilirubin level and fat level for example.
- Reference is now made to
FIG. 2B which shows an implementation ofsubstrate 20, according to one or more illustrative aspects of the disclosure.Substrate 20 is the same as thesubstrate 20 inFIG. 2A , with the addition of lens L1 which is placed on a distal end oflight emitter 22. - Light signals Sλ1 or Sλ2 are emitted from
light emitter 22 at an angle substantially perpendicular to a first planar surface ofsubstrate 20. The first planar surface ofsubstrate 20 is indicated by dottedline 28. Lens L1 provides collimated light signals Sλ1′ or Sλ2′ to be outputted towards the user'stissue 262, as opposed to scattered light signals Sλ1 or Sλ2 shown inFIG. 2A . Lens L1 may also include a polarizing filter (not shown) which polarizes collimated light signals Sλ1′ or Sλ2′. Received light wave signals RSλ1′ or RSλ1′ are reflected towardslight detector 26 at an angle α from layers S1-S5 oftissue 262. Received light wave signals RSλ1′ or RSλ1′ may carry both DC and AC components when detected inlight detector 26. Received light wave signals Sλ1′ or Sλ2′ received at angle α, from the tissue layers S1-S5 oftissue 262 have signal properties that depend on parameters such as the wavelengths of light signals emitted fromlight emitter 22 with or without lens L1, properties of the lens L1 distance d1 between thelight emitter 22 and thelight detector 26, a displacement in the positional location ofsubstrate 20 relative to atissue 262, movement properties of a person wearingsensor device 10 and the like. - Reference is now made to
FIG. 2C which shows an implementation ofsubstrate 20, according to one or more illustrative aspects of the disclosure.FIG. 2C is the same asFIG. 2A with respect tosubstrate 20, having an addition of lens L1 which is placed on a distal end oflight emitter 22 and offset laterally towardslight detector 26. Light signals are emitted fromlight emitter 22 at an angle substantially perpendicular to a first planar surface ofsubstrate 20. The first planar surface ofsubstrate 20 is indicated by dottedline 28. However, lens L1 causes light signals Sλ1′ or Sλ2′ to be deflected away fromlight detector 26 by virtue of lens L1 laterally offsetting the light signals towardslight detector 26. Lens L1 provides collimated light signals Sλ1′ or Sλ2′ as opposed to scattered light signals Sλ1 or Sλ2 shown inFIG. 2A . Received light wave signals RSλ1′ or RSλ1′ received fromtissue 262 towardslight detector 26 are at an angle β from layers S1-S5 oftissue 262. Compared toFIG. 2B , angle β is likely to be more acute than angle α and the distance away fromlight detector 26 where light signals Sλ1′ or Sλ2′ are received intissue 262 is much greater than where light signals Sλ1 or Sλ2 are received fromtissue 262. - Lens L1 may also include a polarizing filter (not shown) which polarizes collimated light signals Sλ1′ or Sλ2′. Utilization of offset lens L1 here eliminates the use of a
reflector 24 to direct light signals away fromlight detector 26. Therefore,sensor device 10 may include multiplelight emitters 22 and respective lenses L1 without anyreflectors 24. Another embodiment discloses thesensor device 10 having a combination oflight emitters 22 andreflectors 24,light emitters 22/lenses L1 andreflectors 24, orlight emitters 22/lenses L1 and noreflectors 24. - Reference is now made to
FIG. 2D which shows an implementation ofsubstrate 20, according to one or more illustrative aspects of the disclosure, Similar toFIG. 2B , lens L1 is placed on a distal end oflight emitter 22. Light is emitted fromlight emitter 22 at an angle substantially perpendicular to a first planar surface of substrate 20 (shown by dotted line 28). However, the embodiment shown inFIG. 2D includes areflector 24 mounted tosubstrate 20 betweenlight detector 26 andlight emitter 22. Light is emitted fromlight emitter 22 and is received offreflector 24 as light signals Sλ1′ or Sλ2′. Light signals Sλ1′ or Sλ2′ then penetrate intotissue 262 away fromlight detector 26 and are received from tissue layers S1-S5 towardslight detector 26 at an angle ε. By comparison angle ε is likely to be more acute than angles β and α. Light signals Sλ1′ or Sλ2′ penetrate intotissue 262 away at a greater distance fromlight detector 26 than as shown in precedingFIGS. 2B-2C . The more acute angle ε and the greater distance may also permit a deeper penetration intotissue 262. - Reference is now made to
FIG. 3 which illustrates features of an area of light interaction in perfused tissue layers S1-S5, according to one or more illustrative aspects of the disclosure. Area 38 a (shown shaded) includes intersection ofillumination sector 36 a with perfused layers S3-S5 that coincides within a portion ofsector 34.Illumination sector 36 a is formed by light signals Sλ1, Sλ1′ or Sλ2, Sλ2′ (not shown) which may be reflected offreflector 24 and/or directed by offset lens L1 intotissue 262. Light signals RSλ3, RSλ4 and RSλ5 are reflected towardslight detector 26 from respective perfused tissue layers S3, S4 and S5. The field of view of reception of received light signals oflight detector 26 is indicated bysector 34. Light intersection area 38 a in perfused tissue layers S3, S4 and S5 is therefore dependent on angle α relative to dashedline 28, so that light components RSλ3, RSλ4 and RSλ5 are reflected towardslight detector 26 from perfused tissue layers S3, S4 and S5. - Accordingly, the baseline DC components in the optical signals measured by the
light detector 26 in the reflective measurement are substantially reduced, by reducing the amount (or altogether excluding) of light components RSλ1 and RSλ2 (not shown), received from respective non-perfused tissue layers S1 and S2. On the other hand, since the optical paths, of the light components RSλ3, RSλ4 and RSλ5 received towards thelight detector 26 from the perfused tissue layers are increased by virtue of angle δ. The light components RSλ3, RSλ4 and RSλ5 indicate a more intense interaction with perfused tissue layers S3, S4 and S5. Thus, light components RSλ3, RSλ4 and RSλ5 may contain significantly more blood related information from pulsatingblood vessels 260 and contribute greater amounts of pulsating AC components to the optical signals captured and measured bylight detector 26. - Reference is now made to
FIG. 4 which shows a method for measuring and processing light signals received from blood vessels, according to one or more illustrative aspects of the disclosure. Step 410 discloses emitting light signals from alight emitter 26 of thesensor device 10. The light signals comprise at least two signals, a first signal in a predefined wavelength to include the blood measurements combined with noise, and a second light signal meant to include noise only. The second signal is inert to changes in blood vessels of the tissue to which the light signal is emitted. The second signal may be emitted in wavelength of 1440 nanometer, - For ease of explanation in the description which follows, the first and second signal emitted towards the user's tissue may be defined as light signals Sλ1 or Sλ2 respectively. Light signals Sλ1 or Sλ2 may pass through one or more components, such as a reflector, lens and the like, as described above. Circuit may include sample and hold circuitry with analogue to digital converters (ADCs) to give a binary digital representation of a series of values associated with specific frequency bands of received light signals RSλ1 or RSλ2. By way of non-limiting example, a reference is now made to the measure of pulse rate which may be derived from
blood vessels 260. The reference applies to the descriptions which follow. - When a light signal enters the body tissue, it is scattered in all directions or bounced around by blood cells and other structures (blood vessels 260) in
tissue 262. The light may either be absorbed into the tissue, or reflect from near-surface tissue layers S1 and S2 which form the epidermis of the skin. Hemoglobin, an oxygen-carrying protein in red blood cells, absorbs lots of blue light (λ=460 nano-meters[nm]) and reflects lots of red light (λ=670 nm). Veins such asblood vessels 260, unlike arteries carry deoxygenated blood, the deoxygenated blood absorbs more red light than the oxygen rich blood in the tissue around the vein. When the blood in veins has unloaded its oxygen to the body's cells exchanging the oxygen (O2) for carbon dioxide CO2, the blood returns to the lungs to replenish the supply of oxygen. Arteries are oxygen rich because this blood has just traveled from the lungs where it picked up oxygen inhaled from the air to the heart where is then pumped throughout the body to deliver its oxygen to the body's cells. Use of shorter wavelengths (λ) such as green light (λ=550 nm) and blue light which is mainly absorbed and received from near-surface tissue layers S1 and S2 to sense the condition of jaundice because of increased levels of bilirubin or melanin. - With respect to the emitting of light signals Sλ1 and Sλ2 in
step 410, the processing module disclosed below may determine chooses whichlight emitter 22 to be used to emit light signals Sλ1 and Sλ2 towardstissue 262. With reference the measure of pulse rate which may be derived fromblood vessels 260, light signals Sλ1 and Sλ2 are set at wavelengths respectively which do and do not absorb in the blood oftissue 262. For pulse measurement light signal Sλ1 has a red wavelength and light signal Sλ2 has a wavelength of 1440 nm. - At
step 420, two light signals are received from the body tissue. The two light signals are collected bylight detector 26 as a result of light signals Sλ1 and Sλ2 emitted according to step 410 and received from tissue layers S1-S5 as respective received light signals RSλ1 and RSλ2. Since light signals Sλ1 and Sλ2 are set at wavelengths which do and do not absorb in the blood oftissue 262, respective received light signals RSλ1 and RSλ2 will have different levels of absorption and different depths of absorption intissue 262. With reference the measure of pulse rate, the movement ofblood vessel 260 will cause both direct current and an alternating current to be collected and measured bylight detector 26 from received light signal RSλ1 . Whereas, with respect to received light signal RSλ2 there will be less alternating current (AC) collected and measured bylight detector 26 and a slight increase or the same level of direct current (DC) collected and measured bylight detector 26. - At
step 430, the conversion module of the device which performs the process converts the first received signal and the second received signal from the time domain to the frequency domain. The converted signals may carry information sampled for at least one (1) second. In some other cases, the received signals contain information sampled for a duration in the range of 1-10 seconds. The output of the conversion to the frequency domain may be represented as two series of values associated with frequency bands. The first series of values is of the first received signal and the second series of values is of the second receivedsignal circuit 20 may include sample and hold circuitry with analogue to digital converters (ADCs) which allows a binary digital representation of received light signal RSλ1 and received light signal RSλ2 in the frequency domain. The binary digital representation of received light signal RSλ1 and received light signal RSλ2 in the frequency domain may be streamed viawireless transceiver 206 to cloud 202 and/orServer 204.Server 204 may be located in a LAN. The server may performsubtraction step 440. Alternatively, or in addition, memory module may be utilized by the processing module to performsubtraction step 440. The received light signal RSλ1 and received light signal RSλ2 are represented in the frequency domain as a series of values, each value in the series of values is associated with a frequency band. For example, 0.5 in the frequency band of 10 Hz, 0.3 in the frequency band of 20 Hz, 0 in the frequency band of 30 Hz, 2.1 in the frequency band of 40 Hz and the like. - In
step 440, the received signal RSλ2 is subtracted from received signal RSλ1 in the frequency domain. That is, each value in a frequency band is subtracted separately. For example, in case there are 10 frequency bands, each of the received signals received RSλ1 and RSλ2 are represented as an array of 10 values, each value represents the amplitude in a specific frequency band. Then, the value infrequency band # 1 of RSλ2 is subtracted from the value infrequency band # 1 of RSλ1, then the values infrequency band # 2 and so forth, such that the output is an array of 10 values. The output of the subtraction is a third signal RSλ3. -
RSλ3=RSλ1−RSλ2 - The subtraction may also be defined as S1(f)−S2(f), as S1(f) denotes the first light signal in the frequency domain and S2(f), At
step 450, the third signal RSλ3 is converted from the frequency domain to the time domain. The output of the third signal RSλ3 in the time domain may be a sinusoidal signal. -
FIG. 5 shows a schematic representation for a device for extracting a biological parameter of a tissue of a person, according to one or more illustrative aspects of the disclosure. The device may be a wearable device, such as a watch used to monitor a biological parameter such as pulse. When the user of the wearable device moves, for example while walking, running, exercising, the movement results in noise added to the signal used to monitor the biological parameter. - The device comprises a
memory module 510 for storing information used to extract the biological parameter. Such information may be a set of mules and operations used to process the signals received from the patient's body tissue. The information may be values representing the received signals, either in the time domain or in the frequency domain. - The device comprises a
sensor module 520 used to collect biological or environmental measurements in the vicinity of the device.Sensor module 520 may include an accelerometer, temperature sensor and moisture sensor, Information collected from thesensor module 520 may be used to initiate the process disclosed inFIG. 4 , as the process is also used to overcome noise resulting from the user's movement. - The device comprises a
processing module 530 for performing the conversions and calculations disclosed in the process ofFIG. 4 . - The device comprises a
display unit 540 for displaying the biological parameters extracted from the light signals received from the patient's blood tissue. -
FIG. 6 shows three signals in the frequency domain that represent the method for extracting a biological parameter of a tissue of a person, according to one or more illustrative aspects of the disclosure. The first signal carries information from the blood vessel located in the tissue. The first signal is shown in thetime domain 610, and in thefrequency domain 615, having pulses in 3 different frequency bands, The second signal comprises substantially only noise. The noise is defined as information resulting from movement of the tissue or movement of the sensor. The second signal is shown in thetime domain 620, and in thefrequency domain 625, having pulses in 2 different frequency bands. The third signal is the subtraction of the second signal from the second signal. The third signal is shown in thetime domain 630, and in thefrequency domain 635, having pulses in one frequency band. - It is noted that the reflective measurement techniques disclosed herein are also very useful for portable as the improved SNR and AC/DC ratios they provide mitigates signals distortions that are induced in the measured signals due to movements of the body part/organ to which the sensor device is attached.
- The structure of the present invention enables emission of various wavelengths and measurements of various properties. Some wavelengths are received differently from the same examined tissue. Hence, the present invention also disclosed selecting an optimal combination of angle between the light source and light detector as well as the distance between them.
- In some exemplary embodiments, the method of the subject matter discloses detecting skin properties of the patient and adjusting light properties of the first light signal and the second light signal according to the detected skin properties. The skin properties may be detected based on the light reflected back from the patient's tissue, or from other sensors, such as an image sensor. The skin properties may include skin's color, level of skin's transparency, level of skin's width, blood vessel's density near the skin, level or skin's fat, hairiness level and a combination thereof. The light properties may include frequency, amplitude, wavelength, duration and a combination thereof. The method of the subject matter may also disclose normalizing the second set of values in multiple frequency bands and the first set of values in multiple frequency bands before subtraction. The subtraction may be performed on vectors representing the sets of values.
- In some exemplary embodiments, the method of the subject matter discloses multiple separate light emitters. The distance between the separate light emitters may be in the range of 1-50 millimeters. In some cases, each of the multiple separate light emitters is configured to emit a separate light signal towards the tissue. In some cases, at least two light emitters of the multiple separate light emitters emit light in different light frequencies. In some cases, at least two light emitters of the multiple separate light emitters emit light in different light intensities.
- In some cases, the processing module adjusts the light intensity of the light signal in case the patient's skin is darker than a set threshold, In some cases, at least one light emitter of the multiple separate light emitters is specifically suitable for fat skin. In some cases, at least one light emitter of the multiple separate light emitters is specifically suitable for dark skin. A light emitter is suitable for a specific skin property according to light properties of the light signals emitted from the light emitters.
- As described hereinabove and shown in the associated Figs., the present invention provides a structure to enable reflective measurement configurations for measuring biological properties of an examined tissue/subject with substantially improved SNR and AC/DC ratios. While particular embodiments of the invention have been described, it will be understood, however, that the invention is not limited thereto, since modifications may be made by those skilled in the art, particularly in light of the foregoing teachings. As will be appreciated by the skilled person, the invention can be carried out in a great variety of ways, employing more than one technique from those described above, all without exceeding the scope of the invention.
Claims (35)
1. A method for extracting a biological parameter of a tissue of a person, the method comprising:
emitting a first light signal and a second light signal towards the tissue, the second light signal is substantially inert to changes in a blood vessel located in the tissue;
collecting a first received signal and a second received signal that are received back from the tissue responsive to the first light signal and the second light signal respectively, the first received signal carrying information from the blood vessel located in the tissue;
converting the first received signal and the second received signal as set of values in multiple frequency bands, wherein a first set of values in multiple frequency bands represents the first received signal and a second set of values in multiple frequency bands represents the second received signal; and
subtracting the second set of values in multiple frequency bands from the first set of values in multiple frequency bands in the frequency domain to obtain a third set of frequency bands, wherein the third set of frequency bands represents a third signal corresponding to the biological parameter of the tissue.
2. The method of claim 1 , wherein the collecting is performed responsive to a delay in the emitting of the first light signal followed by the second light signal towards the tissue.
3. The method of claim 1 , wherein the collecting is performed responsive to the emitting of the first light signal and the second light signal at the same time towards the tissue.
4. The method of claim 1 , further comprising:
converting the third signal from the frequency domain to the time domain.
5. The method of claim 1 , further comprising displaying the biological parameter on a display of a wearable device responsive worn by the person.
6. The method of claim 1 , wherein the emitting of the first and the second wavelength of light is laterally in a direction away from a sensor doing the sensing.
7. The method of claim 1 , wherein the emitting of the first and the second wavelength of light penetrates two different depths of the tissue.
8. The method of claim 1 , wherein the method is performed responsive to a movement of the person.
9. The method of claim 1 , wherein the biological parameter is selected from the group comprising:
a heart rate, a respiratory rate, a peripheral capillary oxygen saturation rate (SPO2), a hemoglobin level, a perspiration level, a blood pressure, a glucose level, a bilirubin level, a stroke volume and a fat level.
10. The method of claim 1 , further comprising detecting skin properties of the patient;
adjusting light properties of the first light signal and the second light signal according to the detected skin properties.
11. The method of claim 10 , wherein the skin properties are selected from a group comprising skin's color, level or skin's fat, hairiness level and a combination thereof.
12. The method of claim 10 , wherein the light properties are selected from a group comprising frequency, amplitude, wavelength, duration and a combination thereof.
13. The method of claim 1 , further comprising normalizing the second set of values in multiple frequency bands and the first set of values in multiple frequency bands before subtraction.
14. The method of claim 1 , wherein the first set of values equals to a numerical function of the first received signal and the second set of values equal to a numerical function of the second received signal.
15. A wearable device to determine a biological parameter of a tissue of a person, the wearable device comprising:
a processing module operatively attached to a display;
a light emitter operatively connected to the control unit and configured to emit a first light signal and a second light signal towards the tissue, the second light signal is defined as substantially not penetrating the tissue;
a light detector operatively connected to the control unit and configured to collect a first received signal and a second received signal that are received back from the tissue responsive to the first light signal and the second light signal respectively;
wherein the processing module converting the first received signal and the second received signal as set of values in multiple frequency bands, wherein a first set of values in multiple frequency bands represents the first received signal and a second set of values in multiple frequency bands represents the second received signal; and
wherein the processing module subtracting the second set of values in multiple frequency bands from the first set of values in multiple frequency bands in the frequency domain to obtain a third set of frequency bands, wherein the third set of frequency bands represents a third signal corresponding to the biological parameter of the tissue.
16. The wearable device of claim 5 , further comprising a lens mounted to a distal end of the light emitter and configured to emit the first and the second wavelength as a collimated light towards the tissue.
17. The wearable device of claim 16 , wherein the collimated light is in a direction away laterally from the light sensor towards the tissue by an offset of a lens.
18. The wearable device of claim 15 , further comprising a reflector disposed between the light emitter and the light sensor, wherein the light from light emitter is received by the reflector in a direction away laterally from the light sensor towards the tissue.
19. The wearable device of claim 15 , further comprising a memory operatively attached to the processing module, wherein the memory stores the first and second set of frequency bands.
20. The wearable device of claim 15 , wherein the output is responsive to a movement of at least one of the person and the tissue, wherein the movement is a source of the extraneous noise sensed by the light sensor.
21. The wearable device of claim 15 , wherein the processing module is configurable to process the difference and to display the biological parameter on the display of the wearable device.
22. The wearable device of claim 15 , wherein the emitting of the first and the second wavelength of light is laterally in a direction away from the light sensor.
23. The wearable device of claim 15 , wherein the emitting of the first and the second wavelength of light penetrates respective first and second depths of the tissue.
24. The wearable device of claim 15 , further comprising an amplifier for converting the received signals received at a photo diode into an analog signal to be processed by the wherein the output of the differential amplifier is responsive to a movement of at least one of the person and the tissue.
25. The wearable device of claim 15 , wherein the biological parameter is selected from the group comprising: a heart rate, a respiratory rate, a peripheral capillary oxygen saturation rate (SPO2), a hemoglobin level, a perspiration level, a blood pressure, a glucose level, a bilirubin level, a stroke volume and a fat level.
26. The wearable device of claim 15 , wherein the light emitter comprises multiple separate light emitters, each of the multiple separate light emitters is configured to emit a separate light signal towards the tissue.
27. The wearable device of claim 26 , wherein at least two light emitters of the multiple separate light emitters emit light in different light frequencies.
28. The wearable device of claim 26 , wherein at least two light emitters of the multiple separate light emitters emit light in different light intensities.
29. The wearable device of claim 26 , wherein the processing module adjusts the light intensity of the light signal according to the patient's skin darkness.
30. The wearable device of claim 26 , wherein the processing module adjusts the light intensity of the light signal according to the patient's skin hairiness.
31. The wearable device of claim 26 , wherein the processing module adjusts the light intensity of the light signal according to the patient's skin thickness.
32. The wearable device of claim 26 , wherein the processing module adjusts the light intensity of the light signal according to the patient's density of blood vessels in the skin.
33. The wearable device of claim 26 , wherein the processing module adjusts the light intensity of the light signal according to the patient's bone density.
34. The wearable device of claim 26 , wherein at least one light emitter of the multiple separate light emitters is adjusted based on the patient's skin fat level.
35. The wearable device of claim 26 , wherein at least one light emitter of the multiple separate light emitters is specifically suitable for dark skin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/001,188 US20230210390A1 (en) | 2020-06-11 | 2021-06-13 | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/898,461 US20210386308A1 (en) | 2020-06-11 | 2020-06-11 | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties |
PCT/IL2021/050711 WO2021250681A1 (en) | 2020-06-11 | 2021-06-13 | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties |
US18/001,188 US20230210390A1 (en) | 2020-06-11 | 2021-06-13 | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/898,461 Continuation US20210386308A1 (en) | 2020-06-11 | 2020-06-11 | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230210390A1 true US20230210390A1 (en) | 2023-07-06 |
Family
ID=78824181
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/898,461 Pending US20210386308A1 (en) | 2020-06-11 | 2020-06-11 | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties |
US18/001,188 Pending US20230210390A1 (en) | 2020-06-11 | 2021-06-13 | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/898,461 Pending US20210386308A1 (en) | 2020-06-11 | 2020-06-11 | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties |
Country Status (2)
Country | Link |
---|---|
US (2) | US20210386308A1 (en) |
WO (1) | WO2021250681A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113260302A (en) | 2018-11-11 | 2021-08-13 | 拜尔比特技术公司 | Wearable device and method for monitoring medical characteristics |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6134458A (en) * | 1998-12-15 | 2000-10-17 | Futrex Inc. | Light probe for a near-infrared body chemistry measurement instrument |
US20100056887A1 (en) * | 2006-11-27 | 2010-03-04 | Pioneer Corporation | Emission sensor device and bioinformation detecting method |
US9044149B2 (en) * | 2012-06-22 | 2015-06-02 | Fitbit, Inc. | Heart rate data collection |
US10537270B2 (en) * | 2016-07-25 | 2020-01-21 | Biobeat Technologies Ltd | Method and device for optical measurement of biological properties |
US11179051B2 (en) * | 2017-05-04 | 2021-11-23 | Garmin Switzerland Gmbh | Pulse spectroscopy |
KR102033914B1 (en) * | 2018-03-05 | 2019-10-18 | 주식회사 바이오메디랩스 | method for measuring blood glucose and wearable type apparatus for the same |
-
2020
- 2020-06-11 US US16/898,461 patent/US20210386308A1/en active Pending
-
2021
- 2021-06-13 US US18/001,188 patent/US20230210390A1/en active Pending
- 2021-06-13 WO PCT/IL2021/050711 patent/WO2021250681A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021250681A1 (en) | 2021-12-16 |
US20210386308A1 (en) | 2021-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10537270B2 (en) | Method and device for optical measurement of biological properties | |
JP4903980B2 (en) | Pulse oximeter and operation method thereof | |
US11033189B2 (en) | Wearable device and system for acquiring physiological information of a subject | |
CN104968259B (en) | System and method for the vital sign information for determining object | |
US7865223B1 (en) | In vivo blood spectrometry | |
US20080015424A1 (en) | Tissue Oximetry Apparatus and Method | |
US20110082355A1 (en) | Photoplethysmography device and method | |
US20200214579A1 (en) | Sensor and methods for continuous non-invasive blood pressure measurement and cardiovascular hemodynamics monitoring in healthcare, rehabilitation and wearable wellness monitors | |
US20140081093A1 (en) | Diagnostic measuring apparatus with integrated spectrometer | |
US20170303788A1 (en) | Wearable device for tissue monitoring with effective ambient light blocking | |
US20220354389A1 (en) | Sensor device for optical measurement of biological properties | |
US20230210390A1 (en) | Sensor device to mitigate the effects of unwanted signals made in optical measurements of biological properties | |
WO2016108056A1 (en) | A ppg-based physiological sensing system with a spatio-temporal sampling approach towards identifying and removing motion artifacts from optical signals | |
Hina et al. | A 186μW Photoplethysmography-Based Noninvasive Glucose Sensing SoC | |
Peng et al. | Development of a reflective PPG signal sensor | |
JP2019505275A (en) | Apparatus and method for measuring the concentration of a compound present in blood | |
CN116269268A (en) | High-precision continuous blood pressure measuring device and method | |
WO2016111696A1 (en) | A ppg-based physiological sensing system with a spatio-temporal sampling approach towards identifying and removing motion artifacts from optical signals | |
US20210386303A1 (en) | Radial artery signal measuring device | |
Maattala et al. | Optimum place for measuring pulse oximeter signal in wireless sensor-belt or wrist-band | |
Leier et al. | Smart photoplethysmographic sensor for pulse wave registration at different vascular depths | |
Reddy et al. | A novel method of measurement of oxygen saturation in arterial blood | |
US20230284905A1 (en) | Blood glucose estimation using near infrared light emitting diodes | |
Cusini et al. | Three-wavelength SPAD-based photoplethysmography | |
Prokop et al. | Application of a multi-sensor set for comparative evaluation of the photoplethysmographic waveforms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION UNDERGOING PREEXAM PROCESSING |
|
AS | Assignment |
Owner name: BIOBEAT TECHNOLOGIES LTD., ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BEN ISHAY, ARIK;SARUSSI, ISRAEL;MAY, JOHANAN;REEL/FRAME:064080/0657 Effective date: 20221221 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |